Published in Blood Weekly, June 1st, 2006
Study 1: Increased survival following stem cell transplantation in chronic myeloid leukemia patients is associated with higher 30-day lymphocyte counts.
"Eighty patients with chronic myeloid leukemia (CML) underwent T cell-depleted stem cell transplantation from an HLA-identical sibling, with add-back of donor T cells on days 30 to 45 and days 60 to 100 in patients in whom grade 2 or greater acute graft-versus-host disease (GVHD) developed.
"The outcomes for 54 patients with chronic-phase (CP) and 26 with advanced-phase (AP)...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
Source: Blood Weekly (2006-06-01)
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.